Efficacy, Toxicity, and Pharmacokinetics of Intra-Arterial Chemotherapy Versus Intravenous Chemotherapy for Retinoblastoma in Animal Models and Patients.

Autor: Daniels AB; Division of Ocular Oncology and Pathology, Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.; Program in Cancer Biology, Vanderbilt University, Nashville, TN, USA.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA., Froehler MT; Cerebrovascular Program, Vanderbilt University Medical Center, Nashville, TN, USA., Kaczmarek JV; Division of Ocular Oncology and Pathology, Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, TN, USA., Bogan CM; Division of Ocular Oncology and Pathology, Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, TN, USA., Santapuram PR; Division of Ocular Oncology and Pathology, Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA., Pierce JM; Division of Ocular Oncology and Pathology, Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, TN, USA., Chen SC; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA., Schremp EA; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA., Boyd KL; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Tao YK; Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA.; Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, TN, USA., Calcutt MW; Department of Chemistry, Vanderbilt University, Nashville, TN, USA., Koyama T; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA., Richmond A; Program in Cancer Biology, Vanderbilt University, Nashville, TN, USA.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.; Tennessee Valley Healthcare System, Department of Veterans Affairs, Nashville, TN, USA.; Department of Pharmacology, Vanderbilt University, Nashville, TN, USA., Friedman DL; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.

Publikováno v: Translational vision science & technology [Transl Vis Sci Technol] 2021 Sep 01; Vol. 10 (11), pp. 10.

Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007-2017.

Autor: Lu JE; Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York City, New York, USA., Francis JH; Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.; Department of Ophthalmology, Weill Cornell Medical College, New York City, New York, USA., Dunkel IJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York City, New York, USA., Shields CL; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Yu MD; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Berry JL; Children's Hospital Los Angeles & the USC Roski Eye Institute, Keck Medical School of the University of Southern California, Los Angeles, California, USA., Kogachi K; Children's Hospital Los Angeles & the USC Roski Eye Institute, Keck Medical School of the University of Southern California, Los Angeles, California, USA., Skalet AH; Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, USA.; Department of Radiation Medicine, Oregon Health & Science University, Portland, Oregon, USA., Miller AK; Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, USA.; Department of Radiation Medicine, Oregon Health & Science University, Portland, Oregon, USA., Santapuram PR; Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Daniels AB; Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Abramson DH; Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York City, New York, USA abramsod@mskcc.org.; Department of Ophthalmology, Weill Cornell Medical College, New York City, New York, USA.

Publikováno v: The British journal of ophthalmology [Br J Ophthalmol] 2019 Sep; Vol. 103 (9), pp. 1272-1277. Date of Electronic Publication: 2018 Oct 25.

The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.

Autor: Youngblood VM; Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee., Kim LC; Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee., Edwards DN; Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University, Nashville, Tennessee., Hwang Y; Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University, Nashville, Tennessee. Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, Tennessee., Santapuram PR; Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee., Stirdivant SM; Metabolon Inc., Durham, North Carolina., Lu P; Department of Biostatistics, Vanderbilt University, Nashville, Tennessee., Ye F; Department of Biostatistics, Vanderbilt University, Nashville, Tennessee., Brantley-Sieders DM; Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University, Nashville, Tennessee. Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. jin.chen@vanderbilt.edu dana.brantley@vanderbilt.edu., Chen J; Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University, Nashville, Tennessee. Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, Tennessee. Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee. jin.chen@vanderbilt.edu dana.brantley@vanderbilt.edu.

Publikováno v: Cancer research [Cancer Res] 2016 Apr 01; Vol. 76 (7), pp. 1825-36. Date of Electronic Publication: 2016 Feb 01.